Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Third Edition contains chapters discussing the unique requirements for the universal critical quality attributes, as well as the specific tests required to characterize and control different types of products, ranging in complexity from small molecules in immediate release oral dosage forms to complex products such as drug-antibody conjugates and mRNA-based products. This substantially expanded revision of the second edition will serve as practical comprehensive reference for scientists, managers, educators, and consultants involved in the development and regulation of pharmaceutical products.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Christopher Riley is the President of Riley and Rabel Consulting Services. He received a bachelor’s degree in Pharmacy (1977) and PhD degree in Pharmaceutical Chemistry (1980) from the University of Bath, UK. He taught Pharmaceutical Chemistry, at the Universities of Florida (1983-6) and the University of Kansas (1986-94), and was a Vice President at DuPont Merck (1994-2001) and ALZA (a division of J&J) (2001-7). He has coauthored more than 140 book chapters and papers in peer-reviewed journals, as well as 5 books. He has extensive experience in CMC regulatory affairs and the development of all types of dosage forms.
Specification of Drug Substances and Products: Development and Validation of Analytical Methods is a fully comprehensive reference on specification setting for pharmaceuticals. The revisions and increased scope of this edition reflect changes in the regional and international regulations and guidelines, which have resulted in or have been driven by changes in approaches to the specification of new drug substances and new drug products.
Some of the notable changes are the increased emphasis on the importance of the analytical target profile, analytical procedure life-cycle management, and continuous method improvement. New topics include regional differences in quality requirements compared with those recommended by the International Council on Harmonization (ICH) (notably revision of the validation guideline, Q2, and publication of a new guideline Q14 Analytical Procedure Development). New chapters include pharmacopeial recommendations, the analytical content of application for clinical trials, marketing authorization applications, an additional chapter on solid-state methods, and chapters on specific dosage forms containing orally administered products, topicals, transdermals, inhalation products, ophthalmics, parenterals, nanoparticles, biosimilars, antibodies and drug–antibody conjugates, oligonucleotides, vaccines, and connected drug–devices combination products. The bioanalysis chapter has been supplemented by a separate chapter on the bioanalysis of nucleotides.
This substantially expanded revision of the 2nd edition will serve as a practical comprehensive reference for scientists, managers, educators, and consultants involved in the development and regulation of pharmaceutical products.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Questo è un articolo print on demand. Bestandsnummer des Verkäufers UHEN9HVICG
Anzahl: Mehr als 20 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 397577419
Anzahl: 3 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 46752378-n
Anzahl: 1 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. 3rd edition NO-PA16APR2015-KAP. Bestandsnummer des Verkäufers 26398799636
Anzahl: 3 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 3rd edition. 894 pages. 11.00x8.75x1.50 inches. In Stock. This item is printed on demand. Bestandsnummer des Verkäufers __0443134669
Anzahl: 2 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. Bestandsnummer des Verkäufers 18398799646
Anzahl: 3 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 46752378
Anzahl: 1 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9780443134661_new
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 46752378-n
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 46752378
Anzahl: Mehr als 20 verfügbar